Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.002 | 1 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.00031 | 1 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00017 | 1 |